Global case tally for COVID-19 nears 124 million as U.S. health experts question AstraZeneca trial data
The company may have included “outdated information” in U.S. trial results for its COVID-19 vaccine, providing an “incomplete view of the efficacy data,” a U.S. federal health agency said in a highly unusual statement released after midnight. AstraZeneca AZN, -2.48% AZN, -3.10% said Monday that interim data from aRead More →